NeuroOne Medical Technologies (NeuroOne Medical Technologies) Operating Cash Flow per Share : $-0.54 (TTM As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is NeuroOne Medical Technologies Operating Cash Flow per Share?

NeuroOne Medical Technologies's operating cash flow per share for the three months ended in Mar. 2024 was $-0.08. NeuroOne Medical Technologies's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.54.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for NeuroOne Medical Technologies's Operating Cash Flow per Share or its related term are showing as below:

NMTC' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -384.5 Med: -3.9 Max: 29.9
Current: -3.9

During the past 13 years, NeuroOne Medical Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 29.90% per year. The lowest was -384.50% per year. And the median was -3.90% per year.

NMTC's 3-Year OCF Growth Rate is ranked worse than
58.43% of 688 companies
in the Medical Devices & Instruments industry
Industry Median: 2.6 vs NMTC: -3.90

NeuroOne Medical Technologies Operating Cash Flow per Share Historical Data

The historical data trend for NeuroOne Medical Technologies's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuroOne Medical Technologies Operating Cash Flow per Share Chart

NeuroOne Medical Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.37

-0.63

-0.80

-0.47

-0.71

NeuroOne Medical Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.22	-0.17	-0.13	-0.16	-0.08

Competitive Comparison of NeuroOne Medical Technologies's Operating Cash Flow per Share

For the Medical Devices subindustry, NeuroOne Medical Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeuroOne Medical Technologies's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NeuroOne Medical Technologies's Price-to-Operating-Cash-Flow falls into.

NeuroOne Medical Technologies Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

NeuroOne Medical Technologies's Operating Cash Flow per Share for the fiscal year that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (A: Sep. 2023 )	=	Cash Flow from Operations (A: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (A: Sep. 2023 )
	=	-12.887	/	18.121
	=	-0.71

NeuroOne Medical Technologies's Operating Cash Flow per Share for the quarter that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-2.175	/	25.910
	=	-0.08

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.54

NeuroOne Medical Technologies Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of NeuroOne Medical Technologies's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuroOne Medical Technologies (NeuroOne Medical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NeuroOne Medical Technologies Corp (NAS:NMTC) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

7599 Anagram Dr., Eden Prairie, MN, USA, 55344

Website

https://www.n1mtc.com

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

Executives

Mark Christianson	10 percent owner, officer: VP, Business Dev and Marketing	10006 LIATRIS LANE, EDEN PRAIRIE MN 55347
Ronald W. Mcclurg	officer: Chief Financial Officer	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344
David A Rosa	director, officer: CEO and President	10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343
Hijaz Haris	officer: VP of Marketing	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344
Morgan C. Frank	10 percent owner	2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02110
Manchester Explorer, L.p.	10 percent owner	MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
James E Besser	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02114
Manchester Management Pr, Llc	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02114
Edward Andrle	director	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DRIVE, EDEN PRAIRIE MN 55344
Wade Fredrickson	10 percent owner	10006 LIATRIS LANE, EDEN PRAIRIE MN 55347
Steve Mertens	officer: Chief Technology Officer	10901 RED CIRCLE DR., SUITE 150, MINNETONKA MN 55343
Scott Heuler	officer: Vice President of Sales	10901 RED CIRCLE DR., SUITE 150, MINNETONKA MN 55343
Paul Buckman	director	12988 VALLEY VIEW RD, EDEN PRAIRIE MN 55402
Suraj Kalia	director	10006 LIATRIS LANE, EDEN PRAIRIE MN 55347